NovoCure Ltd. (NVCR) PT Lowered to $62 at Piper Sandler
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $17.53 +3.42%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Piper Sandler analyst Jason Bednar lowered the price target on NovoCure Ltd. (NASDAQ: NVCR) to $62.00 (from $67.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
